Health
Biotech News Update
Lilly's retatrutide has been offered to a single person via the 'compassionate use' program. Additionally, OpenEvidence will add FDA-cleared AI technology for detecting heart disease.
Coverage timeline — 6 articles
STAT News
CAR-T promise in autoimmunity, GSK's goodbye to leucovorin, and more biotech news
2026-04-10 13:38 UTC
STAT News
Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news
2026-06-08 14:05 UTC
STAT News
Cytokinetics' Myqorzo's trial results, Johnson & Johnson's IBD therapy, and more biotech news from The Readout
2026-05-05 14:35 UTC
STAT News
In this edition of STAT Health Tech: OpenEvidence adds AI to detect heart disease, and Cadence raises $100 million, and more.
2026-06-23 12:54 UTC
STAT News
The "triple-G" weight loss drug, Pfizer's lung cancer trial results, and more biotech news from The Readout
2026-06-23 13:06 UTC
STAT News
Everything you need to know about biotech today from The Readout newsletter
2026-04-22 14:40 UTC